Results 201 to 210 of about 33,699 (271)

Triple Therapy With Budesonide/glycopyrrolate/formoterol Fumarate Used in Asthmatic Coexisting With Covid-19

, 2020
Liang Y, Chen M, Tan C, Tu C, Huang J, Zheng X, Liu J.   +6 more
europepmc   +1 more source

Compatibility study of formoterol fumarate-lactose dry powder inhalation formulations: Spray drying, physical mixture and commercial DPIs

Journal of Drug Delivery Science and Technology
Aiesheh Gholizadeh-Hashjin, F. Monajjemzadeh, T. Ghafourian, Hamed Hamishehkar, A. Nokhodchi   +4 more
semanticscholar   +1 more source

Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.

Pulmonary Pharmacology & Therapeutics
François Rony, M. Cortellini, Alessandro Guasconi, Kusum S Mathews, A. Piccinno, Gianluigi Poli, Frédéric Vanhoutte, Jelle Klein   +7 more
semanticscholar   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Advantages of high-dose dual combination of beclomethasone dipropionate/formoterol fumarate

PULMONOLOGIYA
Bronchial asthma is a chronic inflammatory disease of the respiratory tract which requires a multifaceted approach to treatment. The results of modern studies of asthma treatment have shown that combination of beclomethasone dipropionate (BDP)/formoterol fumarate (FF) has a rapid bronchodilating effect, while improving control over asthma symptoms ...
S. K. Zyryanov, A. B. Strok, S. N. Avdeev   +2 more
openaire   +2 more sources

Formoterol Fumarate Inhalation Powder

Hospital Pharmacy, 2001
Each month, subscribers to The Formulary® Monograph Service receive five to six researched monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada, Terri Levien, Danial E. Baker   +2 more
openaire   +1 more source

Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update

Expert Review of Respiratory Medicine, 2021
Introduction: Aclidinium/formoterol is a long-acting muscarinic antagonist (LAMA) and long-acting β2-agonist (LABA) dual bronchodilator used as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD). The efficacy of aclidinium/formoterol has been demonstrated consistently in patients with moderate-to-severe COPD versus ...
Anthony D, D'Urzo, Dave, Singh, James F, Donohue, Kenneth R, Chapman, Robert A, Wise   +4 more
openaire   +2 more sources

Nebulized formoterol fumarate: Dose selection and pharmacokinetics

Pulmonary Pharmacology & Therapeutics, 2008
To determine a dose of nebulized formoterol fumarate inhalation solution (FFIS) comparable to that of the marketed formoterol fumarate dry powder inhaler (FA, 12microg), two crossover studies were conducted in subjects with COPD. Study 1 was a single-dose, double-blind, double-dummy dose-ranging study in which 47 subjects were randomly assigned to ...
Nicholas J, Gross, Edward, Kerwin, Bernard, Levine, Kenneth T, Kim, Kimberly, Denis-Mize, Mohammad, Hamzavi, Michelle, Carpenter, Mike, Rinehart   +7 more
openaire   +2 more sources

Safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate compared with glycopyrrolate/formoterol fumarate for the treatment of COPD: A systematic review and meta-analysis

Journal of the American Pharmacists Association
Piyush Thathera, Aakriti Garg, Shaista Ahmed, Mohd Ashif Khan   +3 more
openaire   +2 more sources

Evaluating the Real-world Effectiveness and Safety of Formoterol Fumarate and Fluticasone Propionate Combination in Asthma: A Prospective, Multicenter Study.

Journal of Association of Physicians of India
BACKGROUND India bears a significant burden of asthma, and asthma in India is characterized by high mortality rates. Poor adherence to treatment guidelines is observed.
Shital Patil, Rajesh Venkitakrishnan, S. K. Behera, Rahul K Jalan, Manish Kumar Jain, Samadarshi Dutta, Ronak Panwala, Kundan Nivangune, Kamlesh Patel   +8 more
semanticscholar   +1 more source

Formoterol fumarate inhalation solution (Perforomist™) for COPD

Expert Review of Clinical Immunology, 2008
Formoterol fumarate is an effective treatment for chronic obstructive pulmonary disease (COPD) patients with moderate or greater severity of airflow obstruction. Published studies indicate that formoterol has a rapid onset of bronchodilation, which may enhance compliance, and sustained bronchodilation over 12 h, which produces a cumulative effect when ...
openaire   +2 more sources